FindTrial
Sign In

Comparison of two different drug effect for postoperative analgesia in Nephrectomy surgery.

Comparative study of Tramadol and Buprenorphine Transdermal patch for postoperative analgesia in Nephrectomy surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044612
Enrollment
60
Registered
2022-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: N29- Other disorders of kidney and ureter in diseases classified elsewhere

Interventions

Intervention1: Buprenorphine Transdermal Patch 10 mcg/hr for duration 7 Days.: Buprenorphine Transdermal patch 10mcg/hr will be applied 12 hrs prior to Nephrectomy Surgery. Control Intervention1: Bupr

Sponsors

Mahatma Gandhi Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I/II Patient UnderGoing Nephrectomy Surgery Patient Written And Informed Consent.

Exclusion criteria

Exclusion criteria: Allergy to Study Drug ASA Grade III/IV.

Design outcomes

Primary

MeasureTime frame
To compare Analgesic effect postoperatively between Tramadol and Transdermal Buprenorphine patch in Nephrectomy patients.Timepoint: 5-7 days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Col RCGupta

Mahatma Gandhi Medical College and Hospital

birbalbaj@gmail.com8107788625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026